Resveratrol and Its Analogs in Human Diseases

Dear Colleagues,

Numerous studies have indicated that resveratrol is a potential dietary chemopreventive and therapeutic agent due to its cardioprotective, anti-inflammatory, anti-oxidative and anti-cancer properties. However, clinical trials with resveratrol have not been too successful owing to resveratrol’s low bioavailability and rapid metabolism, which is the major challenge for dietary phytochemicals. In recent years, however, several resveratrol analogs have attracted attention due to their improved pharmacokinetic properties and pharmacological potency. The potential of resveratrol and analogs for the treatment of various diseases requires further investigation using adequate preclinical models and, vitally, comprehensive clinical trials.

It is our great pleasure to initiate a Special Issue of Nutrients on “Resveratrol and Its Analogs in Human Diseases” to provide an opportunity for researchers to publish their original or up-to-date reviews on the topic of the effects of resveratrol and its analogs in various diseases. It is our hope to welcome manuscripts with advanced knowledge of the mechanisms of action and improved pharmacokinetics for resveratrol and its potent analogs.

Prof. Dr. Anait S Levenson
Dr. J. Luis Espinoza
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.